The FDA recently issued a safety communication warning about a link between breast implants and certain cancers that can develop in the scar tissue around implants.
This new agency warning does not include Breast Implant-Associated Anaplastic Large Cell Lymphoma which has previously been linked to certain Allergan textured breast implants. Those textured implants were recalled after being linked to 600 illnesses and 33 deaths.
October is Breast Cancer Awareness Month, an annual health campaign that raises awareness and support for the 1 in 8 women in the United States that will develop breast cancer in her lifetime. Bringing awareness to this disease is important because breast cancer is the most common cancer in women worldwide. Sadly, on average a woman in the United States is diagnosed with breast cancer every 2 minutes. Breast cancer also impacts men, though it is rare.
Breast cancer treatment and chances for survival can vary greatly depending on the type of breast cancer and when it is diagnosed. As the more than 3.5 million breast cancer survivors in the United States today are well-aware, treatment may include surgery to remove the cancer (lumpectomy), to remove lymph nodes, or even to remove the breast entirely (mastectomy). Breast cancer treatment also frequently involves some combination of radiation therapy, chemotherapy, hormone therapy, targeted therapy drug therapy, and immunotherapy.
Although death rates have decreased since 1989, nearly 42,000 women in the United States are expected to die in 2019 from breast cancer. The decrease in death rates is believed to be the result of advances in treatment and research, earlier detection through screening, and increased awareness of the disease and its risk factors.
Illinois Personal Injury Lawyer Blog